User Manual
Table Of Contents
- Manufacturer
- Identification and Publication Details
- Regulatory
- Explanation of Symbols
- Conventions
- Important Information
- About
- Intended Use
- Compatibility
- Indications for Use
- Contra-indications
- Training
- Safety
- Electromagnetic Compatibility (EMC)
- Using Batteries Safely
- Examining the Shipment
- Initial Setup
- Rear Panel Connections
- Understanding Battery Operations
- Understanding Wireless Network Operations
- Advanced User Options
- Accessory List
- System Overview
- Getting Started
- Alarms
- Monitoring ECG
- ECG Monitoring Considerations for the MR Environment
- wECG Module and ECG Lead Cable
- Quadtrode Electrodes
- Work Flow for ECG Monitoring
- Selecting the ECG Lead Cable and Quadtrode Electrode Type
- Identifying the Placement Site for the Quadtrode Electrode
- Preparing the Quadtrode Electrode Site
- Attaching the ECG Lead Cable
- Checking the ECG Signal Strength
- Minimizing ECG Waveform Noise
- Positioning the ECG Lead Cable and wECG Module for Scanning
- ECG Waveforms and VS Box
- ECG Menu
- Monitoring SPO2
- Monitoring CO2 (LoFlo Option)
- Monitoring Invasive Blood Pressure
- Indications and Contraindications
- Patient Preparation for IBP Monitoring
- Transducer Component, Connection, and Feature Locations
- MR 400 Preparation for IBP Monitoring
- Adult and Pediatric Patients: Expression MR IBP DPT Kit, A/P (REF 989803194631)
- I. Connecting the Reusable Cable to the MR400
- II. Kit Set Up
- III. Purging Air from the Monitoring Line
- IV. Zeroing, Leveling and Calibration
- V. Connecting the Monitoring Kit to the Patient
- The IBP transducer must not be mounted to the patient, or patient burn may result.
- VI. Fast Flushing
- VII. Checking for Leaks
- VIII. In the MR Room
- Neonatal Patients: Expression MR IBP DPT Kit, I/N (REF 989803194641)
- Adult and Pediatric Patients: Expression MR IBP DPT Kit, A/P (REF 989803194631)
- Zeroing the Pressure Transducer
- P1 (and P2) Menu
- Monitoring Agents and Gases (AGENT Option)
- Monitoring RESP
- Monitoring Temperature
- Monitoring NIBP
- Trend Data and Printing
- Maintenance and Troubleshooting
- General Cleaning Guidelines
- Removing all Power to the MR400
- Removing Power from the Wireless Modules
- User Routine-Checks and Planned Maintenance
- Cleaning, Disinfection, and Damage Inspection
- Sterilization
- Testing Alarms
- Testing a Dropped Wireless Module
- Verification Testing
- Anesthetic Oxygen (O2) Sensor Depletion
- Updating Software
- Calibrating the Touch Screen
- Troubleshooting
- Repair
- Environmental Requirements
- Passing the Product on to another User
- Final Disposal of the Product
- Specifications
- Warranty
- Regulatory Information
- Gating Feature
- Guidelines and References
9‐16MonitoringAgentsandGases(AGENTOption) ExpressionMR400InstructionsforUse
AGENT VS Box
*Valuesdisplayedtothenearest0.1percent
Notes
• No data indication is denoted by three dashes (---) in the agent measurement numeric values
(see page 2-20 for an example). When the agent vaporizer is first turned on, it may take 30–
90 seconds for agent identification and readings to be displayed. Once identification is
established, changes in concentration readings are virtually immediate.
• With a 200 percent change in concentration, an auto zero will occur and full accuracy of
the changed concentration will be accomplished within approximately 30 seconds.
• For the identified agent gases, these abbreviations (and colors) are used:
– Desflurane – Des (light blue)
– Enflurane – Enf (orange)
– Halothane – Hal (pink)
– Isoflurane – Iso (purple)
– Sevoflurane – Sev (yellow)
1
6
4
5
2
3
Item Name Definition
1 Alarm flag area Displays AGENT alarm flags when detected; see page 4-31.
2 Secondary agent Et numeric Is the patient’s detected concentration and type of secondary end-tidal agent, in
volume percent *
3 Secondary agent Fi numeric Is the patient’s detected concentration and type of secondary fractional inspired
agent, in volume percent *
4 Primary agent Et numeric Is the patient’s detected concentration and type of primary end-tidal agent, in
volume percent *
5 Primary agent Fi numeric Is the patient’s detected concentration and type of primary fractional inspired
agent, in volume percent *
6 AGENT VS box label Indicates the Agent parameter, and accesses the MAC window